A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/40 (2006.01) A61K 31/435 (2006.01) A61K 31/44 (2006.01) A61K 31/453 (2006.01) A61K 31/4535 (2006.01) A61K 31/454 (2006.01) A61K 31/473 (2006.01) A61K 31/495 (2006.01) A61K 31/538 (2006.01) A61K 31/5415 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2239487
The present invention relates to the use of compounds of general formula (I) for reducing blood glucose and/or inhibit the secretion, circulation or effect of isulin antagonizing peptides like CGRP or amylin. Hence the compound can be used in the treatment of insulin resistance related to NIDDM (non-insulin- dependent diabetes mellitus) or aging.
La présente invention se rapporte à l'utilisation de composés de la formule générale (I) pour réduire le taux de glycémie et/ou inhiber la sécrétion, la circulation ou l'effet de peptides antagonistes de l'insuline tels que CGRP ou l'amyline. Ce composé peut par conséquent être utilisé pour le traitement de l'insulinorésistance associée au diabète sucré non insulino-dépendant (NIDDM) ou au vieillissement.
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Novel method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1369666